Real Clear Markets: The Right’s New Free-Enterprise Detractors Take Aim at Private Equity

Real Clear Markets: The Right’s New Free-Enterprise Detractors Take Aim at Private Equity

A new think tank by the name of American Compass recently made headlines as a “conservative” foe of private equity by launching its new “Returns Counter.” This project purports to compare the returns of private equity against public capital markets, and was launched with a politicized primer on mergers and acquisitions, private equity, and hedge fund investments. Wells King, research director at…

Read More

A Behavioral Economics Perspective: Why People are Perfectly Rational for Going to Work Amidst COVID-19

A Behavioral Economics Perspective: Why People are Perfectly Rational for Going to Work Amidst COVID-19

Tensions surrounding the COVID-19 lockdowns are exceptionally high. Protestors across the US, Germany, France, and Spain—to name just a few—have rallied en masse to demand the lifting of legally-imposed quarantines. Now that economies have begun to reopen, social media has become its own battleground with many urging—even outright shaming—others to stay home and not go to work. So why hasn’t…

Read More

LSPI and other organizations join American Energy Alliance in opposing the biofuel bailout

LSPI and other organizations join American Energy Alliance in opposing the biofuel bailout

May 20, 2020 The Honorable Donald J. TrumpPresident of the United StatesThe White House1600 Pennsylvania Avenue NWWashington, DC 20500 Dear Mr. President: Thank you for your leadership in this most challenging time. As you take steps to restore the economy, we write to express our concern about a misguided policy response being pushed from some quarters. Tariffs on imported oil…

Read More

Elizabeth Warren and AOC Get Everything Wrong About M&A

Elizabeth Warren and AOC Get Everything Wrong About M&A

Arthur Schopenhauer once quipped that if it were constantly repeated with great solemnity, nothing was too absurd for people to believe. After reading the preliminary Pandemic Anti-Monopoly Act from Sen. Elizabeth Warren and Rep. Alexandria Ocasio-Cortez, I find myself more seriously contemplating absurdity. This proposal is a study in Schopenhauer’s point: though couched in great solemnity, both the act itself and the…

Read More

Acton: How Private Institutions like the Church can respond to the Coronavirus pandemic

Acton: How Private Institutions like the Church can respond to the Coronavirus pandemic

If you had you asked someone on New Year’s Day of 2020 what they envisioned the year ahead might look like, few would’ve imagined that the first few months would be spent canceling trips, events, and academic semesters. Families and college students hadn’t planned to spend their spring break in quarantine. Most businesses didn’t enter the year in fear of…

Read More

Real Clear Markets: Americans Must Be Allowed to Safely Get Back to Work

Real Clear Markets: Americans Must Be Allowed to Safely Get Back to Work

Make “Safety” not “Essential Services” the Test Ravaged by COVID-19, the American economy is on the precipice of economic free fall. Federal Reserve Bank of St. Louis President James Bullard has forecasted a 30% U.S. unemployment in the second quarter and a possible GDP plunge of 50%. Goldman Sachs has made similar warnings about our economic trajectory. American businesses are not merely struggling with…

Read More

Free The People: FDA Approval Process for New Drugs is a Death Sentence for Americans

Free The People: FDA Approval Process for New Drugs is a Death Sentence for Americans

Over the past four decades, the Food and Drug Administration (FDA) has been approving new prescription drugs faster. That’s a great thing, since quicker approvals give terminally-ill patients faster access to potentially life-saving treatments. Of course, some critics aren’t happy, and it’s leading them to wonder if the FDA needs to slow “its drug approval roll.” But slowing down the approval process by bolstering…

Read More